Science Angel Syndicate

Science Angel Syndicate, founded in 2021 and based in Bristol, UK, is an angel investment group focused on early-stage scientific startups. The syndicate brings together a community of entrepreneurs and investors dedicated to backing groundbreaking scientific discoveries that have the potential to make a significant societal impact. With a focus on disruptive technologies at the intersection of biology, chemistry, physics, and computer science, the group is particularly interested in companies that align with the emerging Industry 5.0, where human intelligence is enhanced by cognitive computing and automation. Science Angel Syndicate has made 15 investments across various sectors, including biotechnology, drug discovery, and healthcare devices, with companies like MitoRx Therapeutics and Neuronostics being part of their portfolio. The syndicate supports startups that aim to address critical challenges related to health and the environment, providing not only capital but also access to a network of experts across scientific and commercial domains. The syndicate's unique approach involves leveraging the collective knowledge and experience of its members to thoroughly assess the potential of frontier scientific companies. This collaborative method ensures that investments are made in technologies that are not only innovative but also commercially viable and scalable.